Join
Live feed
·
PRReleasevia Quantisnow
Merrimack Pharmaceuticals Inc. logo

Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

ByQuantisnow·Wall Street's wire, on your screen.
MACK· Merrimack Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MACK (Merrimack Pharmaceuticals Inc.) and more on Quantisnow.